Barely Significant
← all excerpts

Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting clusterin improves response to paclitaxel.

J Exp Clin Cancer Res · 2011 · PMC3287343 · PMID 22185350

Europe PMCDOI
1
hedged sentence
0.0900
closest p · 1.8× alpha
0.0900
boldest claim

The sentences

marginal significancep = 0.09so close (0.05 < p ≤ 0.1)
Among early stage ovarian cancer patients who underwent complete cytoreductive surgery including systematic pelvic and para-aortic lymphadenectomy, the association between the expression of CLU protein in ovarian cancer tissues and several clinicopathological factors revealed that age (p = 0.83), histologic subtype (p = 0.32) were not related to CLU expression, while FIGO stage showed the relation to CLU expression with marginal significance (p = 0.09) (Table 3 ).

also in 5,069 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.